erythrosine has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikata, T; Morimoto, K; Tounai, T | 1 |
| Klaverkamp, J; Völkl, KP | 1 |
2 other study(ies) available for erythrosine and thromboxane b2
| Article | Year |
|---|---|
[Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Topics: 6-Ketoprostaglandin F1 alpha; Acrylates; Animals; Blood Vessels; Depression, Chemical; Fluoresceins; Male; Methacrylates; Rats; Rats, Inbred Strains; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Thromboxane B2; Thromboxane-A Synthase | 1990 |
Maintenance of platelet viability after platelet-labeling with fluorescein isothiocyanate.
Topics: Adenosine Diphosphate; Animals; beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Cell Survival; Fluorescein-5-isothiocyanate; Fluoresceins; Platelet Aggregation; Platelet Factor 4; Rats; Ristocetin; Thiocyanates; Thromboxane B2 | 1984 |